About
Dr. Elizabeth Ralevski is an Assistant Professor of Psychiatry at Yale University School of Medicine and Project Director of the Substance Abuse Treatment Program. She holds affiliations with the Connecticut Mental Health Center, VA Alcohol Research Center, and Yale Ventures. She earned her PhD from York University (2000) and completed a postdoctoral fellowship at Harvard Medical School (2001). Her research focuses on dual diagnosis treatment for alcoholism and psychiatric comorbidities (e.g., PTSD, schizophrenia), stress-related factors in addiction, and pharmacological interventions. Recent work includes studies on cognitive processing therapy for veterans with opioid use disorder and PTSD, neurosteroids' role in AUD/PTSD, and progesterone's stress-attenuating effects in AUD/PTSD patients.
Her research trends emphasize translational studies in veterans' mental health, neurobiological mechanisms of addiction, and personalized treatment approaches for comorbid conditions. She collaborates with experts like Dr. Ismene Petrakis and Dr. Erin O'Brien, focusing on clinical trials and pharmacotherapy. Dr. Ralevski leads initiatives at the VA Alcohol Research Center and Substance Abuse Treatment Program, addressing alcohol dependence and PTSD in veterans. No formal awards are listed, but her work has implications for improving dual-diagnosis care. She actively publishes in journals like American Journal on Addictions and Frontiers in Neuroendocrinology.
Labs/Teams: She is affiliated with the VA Alcohol Research Center and leads the Substance Abuse Treatment Program at Yale School of Medicine.